Cargando…
Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
Metastatic uveal melanoma (mUM) is an advanced ocular malignancy characterized by a hepatotropic pattern of spread. As the incidence of brain metastases (BM) in mUM patients has been thought to be low, routine CNS surveillance has not been recommended. Notably, no formal assessment of BM incidence i...
Autores principales: | Wei, Alexander Z., Uriel, Matan, Porcu, Agata, Manos, Michael P., Mercurio, Ann C., Caplan, Michael M., Hulse, Liam, Seedor, Rino S., Holovatska, Marta, Francis, Jasmine, Khan, Shaheer A., McDonnell, Diana E., Bogomolny, Dmitry, Sato, Takami, Marr, Brian P., Haq, Rizwan, Orloff, Marlana, Shoushtari, Alexander, Carvajal, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540230/ https://www.ncbi.nlm.nih.gov/pubmed/36212499 http://dx.doi.org/10.3389/fonc.2022.961517 |
Ejemplares similares
-
Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Seedor, Rino S., et al.
Publicado: (2021) -
An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis
por: Seedor, Rino S., et al.
Publicado: (2020) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2020) -
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
por: Chua, Vivian, et al.
Publicado: (2019)